ATE375161T1 - Umkehremulsionszusammensetzung mit calcitriol und clobetasol-17-propionat und ihre kosmetische und dermatologische verwendung - Google Patents

Umkehremulsionszusammensetzung mit calcitriol und clobetasol-17-propionat und ihre kosmetische und dermatologische verwendung

Info

Publication number
ATE375161T1
ATE375161T1 AT05777134T AT05777134T ATE375161T1 AT E375161 T1 ATE375161 T1 AT E375161T1 AT 05777134 T AT05777134 T AT 05777134T AT 05777134 T AT05777134 T AT 05777134T AT E375161 T1 ATE375161 T1 AT E375161T1
Authority
AT
Austria
Prior art keywords
calcitriol
clobetasol
propionate
cosmetic
emulsion composition
Prior art date
Application number
AT05777134T
Other languages
English (en)
Inventor
Leslie Zanutto
Sandrine Orsoni
Laurent Fredon
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34946892&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE375161(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Sa filed Critical Galderma Sa
Application granted granted Critical
Publication of ATE375161T1 publication Critical patent/ATE375161T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P14/00—Formation of materials, e.g. in the shape of layers or pillars
    • H10P14/20—Formation of materials, e.g. in the shape of layers or pillars of semiconductor materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Manufacturing & Machinery (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05777134T 2004-06-17 2005-06-15 Umkehremulsionszusammensetzung mit calcitriol und clobetasol-17-propionat und ihre kosmetische und dermatologische verwendung ATE375161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0406612A FR2871699A1 (fr) 2004-06-17 2004-06-17 Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie

Publications (1)

Publication Number Publication Date
ATE375161T1 true ATE375161T1 (de) 2007-10-15

Family

ID=34946892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05777134T ATE375161T1 (de) 2004-06-17 2005-06-15 Umkehremulsionszusammensetzung mit calcitriol und clobetasol-17-propionat und ihre kosmetische und dermatologische verwendung

Country Status (15)

Country Link
US (1) US20050281850A1 (de)
EP (1) EP1758591B2 (de)
JP (1) JP2008502662A (de)
KR (1) KR20070028424A (de)
CN (1) CN1972693A (de)
AT (1) ATE375161T1 (de)
AU (1) AU2005261570A1 (de)
BR (1) BRPI0510893A (de)
CA (1) CA2567682A1 (de)
DE (1) DE602005002844T3 (de)
ES (1) ES2296218T5 (de)
FR (1) FR2871699A1 (de)
MX (1) MXPA06014406A (de)
RU (1) RU2007101539A (de)
WO (1) WO2006005843A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
EP1917072B1 (de) 2005-06-01 2013-02-27 Stiefel Research Australia Pty Ltd Vitaminformulierung
WO2007038993A1 (en) * 2005-09-22 2007-04-12 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Preparation, in particular cosmetic preparation, production and use thereof
FR2903602B1 (fr) * 2006-07-12 2012-10-26 Seppic Sa Formulation injectable a liberation prolongee de principes actifs, procede pour sa preparation
KR20110113664A (ko) * 2006-08-29 2011-10-17 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970048A1 (de) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topische Zusammensetzung mit Vitamin D
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
JP2012513387A (ja) * 2008-12-23 2012-06-14 ガルデルマ・ソシエテ・アノニム 感水性の活性成分を含む、局所用医薬組成物
BR112013023458B1 (pt) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd composição oftálmica, e, método para fabricar a composição oftálmica
WO2013162723A1 (en) * 2012-04-27 2013-10-31 Dow Corning Corporation Topical formulation compositions containing silicone based excipients to deliver actives to a substrate
NZ707855A (en) * 2012-11-06 2018-11-30 Rochal Ind Llc Delivery of biologically-active agents using volatile, hydrophobic solvents
EP3055349A1 (de) 2013-10-11 2016-08-17 Bewi Styrochem Oy Polystyrolküglechen mit niedriger wärmeleitfähigkeit
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
KR102480670B1 (ko) * 2014-10-31 2022-12-23 가부시키가이샤 시세이도 유중 수형 유화 자외선 차단 화장료
WO2017037663A1 (en) 2015-09-02 2017-03-09 Cadila Healthcare Limited Topical compositions comprising corticosteroids
FR3062059B1 (fr) * 2017-01-26 2020-08-28 Laboratoires M&L Base de formulation cosmetique concentree description
US20210069118A1 (en) * 2017-10-06 2021-03-11 Université De Bordeaux New polymeric emulsifier and uses thereof for the encapsulation of hydrophobic or hydrophilic active compounds
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
JP2021529811A (ja) * 2018-07-11 2021-11-04 クレキシオ バイオサイエンシーズ エルティーディー． 局所用デトミジン製剤
CN109833291B (zh) * 2019-04-03 2022-08-26 普霖贝利生物医药研发(上海)有限公司 一种稳定的丙酸氯倍他索软膏及其制备方法
WO2021046444A1 (en) * 2019-09-06 2021-03-11 Encore Dermatology, Inc. Topical compositions comprising a corticosteroid for the treatment of psoriasis in pediatric patients
IT201900020526A1 (it) * 2019-11-07 2021-05-07 Francesco Leva Formulazione trifasica emulsionabile e suoi impieghi terapeutici e/o cosmetologici

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US5898037A (en) * 1992-11-13 1999-04-27 Marx; Alvin J. Formulations of magnesium compounds for local application and methods of treatment using the same
US6348199B1 (en) * 1993-03-24 2002-02-19 Joseph Vernice Skin treatment cream
FR2742354B1 (fr) * 1995-12-15 1998-01-23 Oreal Emulsion e/h/e stable contenant un actif cosmetique et/ou dermatologique sensible a l'eau
FR2753626B1 (fr) * 1996-09-20 1998-11-06 Centre International De Rech Dermatologiques Galderma Cird Galderma Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
US20010002396A1 (en) * 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
ES2388425T5 (es) * 1999-04-23 2020-02-12 Leo Pharma As Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
FR2828100B1 (fr) * 2001-08-02 2004-09-24 Galderma Res & Dev Composition de type emulsion inverse contenant de la dhea et/ou ses precurseurs ou derives, et ses utilisations en cosmetique et en dermatologie
DE10154627A1 (de) * 2001-11-07 2003-05-15 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US6797685B2 (en) * 2002-04-26 2004-09-28 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Liquid laundry detergent with emulsion layer
CA2505406A1 (en) * 2002-12-17 2004-07-01 Galderma Sa Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
JP2006525959A (ja) * 2003-02-05 2006-11-16 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ 水の存在に感受性の少なくとも一つの活性剤を含む逆エマルションタイプの組成物、並びに化粧品及び皮膚科学におけるその使用

Also Published As

Publication number Publication date
EP1758591B2 (de) 2010-12-15
AU2005261570A1 (en) 2006-01-19
US20050281850A1 (en) 2005-12-22
MXPA06014406A (es) 2007-02-19
ES2296218T3 (es) 2008-04-16
EP1758591B1 (de) 2007-10-10
DE602005002844D1 (de) 2007-11-22
DE602005002844T3 (de) 2011-06-30
KR20070028424A (ko) 2007-03-12
WO2006005843A1 (fr) 2006-01-19
CA2567682A1 (fr) 2006-01-19
CN1972693A (zh) 2007-05-30
DE602005002844T2 (de) 2008-07-10
BRPI0510893A (pt) 2007-11-27
RU2007101539A (ru) 2008-07-27
FR2871699A1 (fr) 2005-12-23
EP1758591A1 (de) 2007-03-07
JP2008502662A (ja) 2008-01-31
ES2296218T5 (es) 2011-05-05

Similar Documents

Publication Publication Date Title
DE602005002844D1 (de) Umkehremulsionszusammensetzung mit calcitriol und clobetasol-17-propionat und ihre kosmetische und dermatologische verwendung
DE59913995D1 (de) Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
DE59914308D1 (de) Emulgatorfreie feindisperse Systeme vom Type Öl-in-Wasser und Wasser-in-Öl
ATE350104T1 (de) Emulgatorfreie feindisperse systeme vom typ wasser-in-öl
ATE345840T1 (de) Emulgatorfreie feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
ATE359862T1 (de) Silicon enthaltende öl-in-öl emulsionen, dispersionen solcher emulsionen und verwendung
DE69900217D1 (de) Ö/W Emulsionen mit eimen hohen Wachsgehalt und ihre kosmetische und dermatologische Verwendung
EP1291010A3 (de) Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon
BR0207374A (pt) Emulsões e dispersões aquosas de fitosteróis
ATE434944T1 (de) Farbstoff-emulsion und emulgatorzusammensetzung sowie deren verwendung
ZA200505692B (en) Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
BRPI0411549A (pt) composição tensoativa, emulsão óleo-em-água ou água-em-óleo, produto cosmético ou de tratamento pessoal, recipiente, e, uso de uma composição tensoativa
MXPA04001007A (es) Emulsion inversa que contiene dihidroepiandrosterona.
EP1310235A3 (de) Emulgatorfreie kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Hydroxybenphenonen
DE69900885D1 (de) W/o-emulsionen mit hohem wachsgehalt und deren verwendung im kosmetischen und dermatologischen bereich
BRPI0511206A (pt) composição farmacêutica anidra e uso de um ungüento oleaginoso
DE69900170D1 (de) Wasser-in-Öl emulgierte kosmetische oder dermatologische flüssige Zusammnensetzung
JP2019116452A5 (de)
WO2007059888A3 (en) Oil-in-water emulsions based on special emulsifiers
BR0304135A (pt) Método melhorado para a formação de uma fase estável de emulsão baseada em emulsificante polimérico, e, método para melhorar a capacidade de homogeneização de um explosivo em emulsão
ATE525110T1 (de) Inverse emulsionszusammensetzung mit ivermectin und verwendung davon in der kosmetik und in der dermatologie
ATE427099T1 (de) Kosmetische zusammensetzung enthaltend eine mischung aus elastomeren
ATE371433T1 (de) Mineralorganische sonnenschutzzusammensetzung zum aufbringen mit einer antriebspumpe
ATE469632T1 (de) Kosmetische emulsion enthaltend feste partikeln
Gullapalli et al. Effect of methylcellulose on the stability of oil-in-water emulsions: influence of the disperse phase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties